Amendment_3_NIAID-DAIDS-NIHAI2014014_FINAL.pdf

Amendment No. 3

NIAID-DAIDS-NIHAI2014014

“Staged Vaccine Development”

Solicitation Number:

Amendment Number:

Amendment Issue Date:

NIAID-DAIDS-NIHAI2014014

Three (3)

November 18, 2014

Proposal Due Date/Time:

Monday, December 1, 2014, at 3:00 PM, Local Time (UNCHANGED)

Issued By: Michelle L. Scala Contracting Officer

OA/DEA/NIAID/NIH/DHHS

5601 Fisher Lane, Room 3D10, MSC 9821 Bethesda, Maryland 20892-9821

Points of Contact: PRIMARY:

patelki@niaid.nih.gov Kishan Patel, Contract Specialist Phone: 240-669-5157

SECONDARY:

mscala@niaid.nih.gov Michelle L. Scala, Contracting Officer Phone: 240-669-5156

The purpose of this amendment is to: 1) revise Section A – Solicitation/Contract Format, Item No. 6, Issued By, item 11, and Secondary Point of Contact, to update the mailing address and contact information for the Contract Specialist and Contracting Officer;

2) correct the “Not to Exceed” amount indicated for Stage III in SECTION L – INSTRUCTIONS, CONDITIONS AND NOTICES TO OFFERORS, paragraph 1, General Information, subparagraph c, Estimate of Effort; 3) revise the “Not to Exceed” amount indicated for Stage III in ATTACHMENT 3 – BROAD AGENCY ANNOUNCEMENT DESCRIPTION: and 4) amend ATTACHMENT 7 – ADDITIONAL BUSINESS PROPOSAL INSTRUCTIONS AND UNIFORM COST ASSUMPTIONS, Section 3, Uniform Cost Assumptions, Paragraph 1, Technical Cost Assumptions, 2nd paragraph, to correct the “Not To Exceed” amount for Stage III.

Offerors must acknowledge receipt of this Amendment by identifying this amendment number and date of the amendment on each copy of the proposal submitted. Failure to receive your acknowledgement may result in the rejection of your proposal. Except as provided herein, all terms and conditions of the solicitation remain unchanged and in full force and effect.

AMENDMENT #3, NIAID-DAIDS-NIHAI2014014

mailto:patelki@niaid.nih.gov mailto:anhughes@niaid.nih.gov

SECTION A – SOLICITATION/CONTRACT FORM, Item 6, Issued By, is hereby revised to read as follows:

6. ISSUED BY:

Office of Acquisitions Division of Extramural Activities National Institute of Allergy and Infectious Diseases National Institutes of Health Department of Health and Human Services 5601 Fishers Lane, Room 310, MSC 9821

BETHESDA, MD 20892-9821

If using overnight delivery, ROCKVILLE, MD 20852 should be used.

SECTION A – SOLICITATION/CONTRACT FORM, Item 11, is hereby revised to read as follows:

11. FOR INFORMATION CALL: Kishan Patel

PHONE: 240-669-5157

e-MAIL: patelki@niaid.nih.gov

COLLECT CALLS WILL NOT BE ACCEPTED.

SECTION A – SOLICITATION CONTRACT FORM, bottom left hand side of page 1, Secondary Point of Contact, is revised to read as follows:

Secondary Point of Contact:

Michelle L. Scala, Contracting Officer Phone: 240-669-5156 e-MAIL: Mscala@niaid.nih.gov

COLLECT CALLS WILL NOT BE ACCEPTED.

SECTION L - INSTRUCTIONS, CONDITIONS AND NOTICES TO OFFERORS, paragraph 1, General Information, subparagraph c, Estimate of Effort, is hereby revised to read as follows:

It is expected that a completion type contract will be awarded as a result of this solicitation.

To assist you in the preparation of your proposal, the Government considers the estimated maximum amount of each of the three planned stages to be approximately as follows:

Stage I - Approximately $100,000/year for a maximum performance period of 2 years. (Not to Exceed: $200,000 for Stage I) Stage II - Approximately $5,000,000/year for a maximum performance period of 3 years. (Not to Exceed: $15,000,000 for Stage II) Stage III - Maximum performance period of 3 years. (Not to Exceed: $2,000,000 for Stage

III)

This information is furnished for the offeror's information only and is not to be considered restrictive for proposal purposes.

ATTACHMENT 3 – BROAD AGENCY ANNOUNCEMENT DESCRIPTION, 6th paragraph, is hereby revised to read as follows:

NIAID plans to use a staged approach for performance of the work. The contract will be awarded for up to a 2 year base period to support Stage 1 activities and will include options for Stage II

AMENDMENT #3, NIAID-DAIDS-NIHAI2014014

mailto:patelki@niaid.nih.gov mailto:Mscala@niaid.nih.gov and Stage III activities that will be milestone driven, based on the Go-no-Go criteria. Below are the estimated cost (direct and indirect costs combined) and period of performance of each Stage:

Stage I: Approximately $100,000 per year for a maximum performance period of 2 years Stage II: Approximately $15,000,000 for a maximum performance period of 3 years Stage III: Approximately $2,000,000 for maximum performance period of 3 years

ATTACHMENT 7 – ADDITIONAL BUSINESS PROPOSAL INSTRUCTIONS AND

UNIFORM COST ASSUMPTIONS, Section 3, Uniform Cost Assumptions, Paragraph 1, Technical Cost Assumptions, 2nd paragraph, is revised to read as follows:

Stage I contracts will be awarded for up to a 2 year base period. Of these 4 to 6 awards, only 1 or 2 will move on to Stage II and/or III. Options will be included for Stage II and III activities.

Options will be exercised based on go/no-go decisions. Below are the estimated cost and period of performance of each Stage:

Stage I: Approximately $100,000/year for a minimum of 1 year and maximum performance period of 2 years Stage II: Approximately $15,000,000 for a maximum performance period of 3 years Stage III: Approximately $2,000,000 for maximum performance period of 3 years

END OF AMENDMENT # 3, NIAID-DAIDS-NIHAI2014014

AMENDMENT #3, NIAID-DAIDS-NIHAI2014014